129 related articles for article (PubMed ID: 7357086)
1. Prediction of chemotherapy response in human leukemia using an in vitro chemotherapy sensitivity test on the leukemic colony-forming cells.
Park CH; Amare M; Savin MA; Goodwin JW; Newcomb MM; Hoogstraten B
Blood; 1980 Apr; 55(4):595-601. PubMed ID: 7357086
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy sensitivity assessment of leukemic colony-forming cells with in vitro simultaneous exposure to multiple drugs: clinical correlations in acute nonlymphocytic leukemia.
Park CH; Amare M; Morrison FS; Maloney TR; Goodwin JW
Cancer Treat Rep; 1982 Jun; 66(6):1257-61. PubMed ID: 7083232
[TBL] [Abstract][Full Text] [Related]
3. [An in vitro chemotherapy sensitivity test on leukemic colony-forming cells (L-CFU) and its clinical evaluation].
Moriyama Y; Urushiyama M; Hirosawa H; Koyama S; Takai K; Fujiwara M; Kishi K; Takahashi M; Sakai C; Sanada M; Shibata A
Gan To Kagaku Ryoho; 1982 Oct; 9(10):1749-54. PubMed ID: 7184371
[TBL] [Abstract][Full Text] [Related]
4. Impact of in vivo administration of interleukin 3 on proliferation, differentiation, and chemosensitivity of acute myeloid leukemia.
Gore SD; Weng LJ; Jones RJ; Cowan K; Zilcha M; Piantadosi S; Burke PJ
Clin Cancer Res; 1995 Mar; 1(3):295-303. PubMed ID: 9815985
[TBL] [Abstract][Full Text] [Related]
5. Effects of chemotherapy on bone marrow stroma in mice with acute myelogenous leukemia. Correlation with CFU-C and CFU-D.
Ben-Ishay Z; Prindull G; Sharon S; Borenstein A
Leuk Res; 1985; 9(8):1059-67. PubMed ID: 3862923
[TBL] [Abstract][Full Text] [Related]
6. Acute leukemia in adults: assessment of remission induction with combination chemotherapy by clinical and cell-culture criteria.
Curtis JE; Cowan DH; Bergsagel DE; Hasselback R; McCulloch EA
Can Med Assoc J; 1975 Aug; 113(4):289-94. PubMed ID: 1056807
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of in vitro colony and cluster formation in acute nonlymphocytic leukemia.
Goldberg J; Tice D; Nelson DA; Gottlieb AJ
Am J Med Sci; 1979; 277(1):81-4. PubMed ID: 426001
[TBL] [Abstract][Full Text] [Related]
8. The effect of a prolonged in vitro exposure to 1-beta-D arabinofuranosylcytosine and deoxycytidine on the survival of normal (CFU-GM) and leukemic (L-CFU) human myeloid progenitor cells in suspension culture.
Grant S; Bhalla K; Arlin Z; Howe CW
Exp Hematol; 1990 Jan; 18(1):41-8. PubMed ID: 2298268
[TBL] [Abstract][Full Text] [Related]
9. Prediction of response to chemotherapy in acute leukemia by in vitro drug sensitivity testing on leukemic stem cells.
Gustavsson A; Olofsson T
Cancer Res; 1984 Oct; 44(10):4648-52. PubMed ID: 6590116
[TBL] [Abstract][Full Text] [Related]
10. Serial quantitative observations of leukemic and normal hematopoietic cells in the bone marrow of acute leukemia under chemotherapy.
Ohshima T; Amaki I
Tohoku J Exp Med; 1976 May; 119(1):27-40. PubMed ID: 1065964
[TBL] [Abstract][Full Text] [Related]
11. [Drug sensitivity of human acute myelocytic leukemia cells (HL-60) and normal human myelocytes (CFU-C) in a co-culture].
Himori T; Ohnuma T; Wakui A
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1170-8. PubMed ID: 6575724
[TBL] [Abstract][Full Text] [Related]
12. In vitro hematopoiesis following induction chemotherapy for acute leukemia.
Beyer GS; Bruno E; Hoffman R
Cancer Res; 1985 Nov; 45(11 Pt 2):5921-5. PubMed ID: 4053063
[TBL] [Abstract][Full Text] [Related]
13. An analysis of the relationship of leukemic cell kinetics to chemotherapy.
Killmann SA; Ernst P
Bibl Haematol; 1973; 39():1037-45. PubMed ID: 4777986
[No Abstract] [Full Text] [Related]
14. Adult acute leukaemia.
Atkinson K; Wells DG; Clink HM; Kay HE; Powles R; McElwain TJ
Br J Cancer; 1974 Sep; 30(3):272-8. PubMed ID: 4141625
[TBL] [Abstract][Full Text] [Related]
15. [Kinetics of circulating hematopoietic stem cells following chemotherapy in patients with hematopoietic malignancies].
Tamura K; Kosaka M; Mizuguchi T; Miyamoto Y
Rinsho Ketsueki; 1990 May; 31(5):647-54. PubMed ID: 1697629
[TBL] [Abstract][Full Text] [Related]
16. Prediction of remission in adult acute leukemia: development and testing of predictive models.
Smith TL; Gehan EA; Keating MJ; Freireich EJ
Cancer; 1982 Aug; 50(3):466-72. PubMed ID: 7093888
[TBL] [Abstract][Full Text] [Related]
17. Changing response of clonogenic myeloid leukemia blasts to granulocyte-macrophage colony-stimulating factor (GM-CSF) during anti-leukemic therapy--a case report on the basis of a clinical phase II trial.
Hiddemann W; Zühlsdorf M; Wörmann B; Koenigsmann M; Büchner T
Leuk Res; 1990; 14(4):347-52. PubMed ID: 2185381
[TBL] [Abstract][Full Text] [Related]
18. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
[TBL] [Abstract][Full Text] [Related]
19. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
Lemoli RM; Gulati SC; Strife A; Lambek C; Perez A; Clarkson BD
Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
[TBL] [Abstract][Full Text] [Related]
20. Transplant characteristics: minimal residual disease and impaired megakaryocytic colony growth as sensitive parameters for predicting relapse in acute myeloid leukemia.
Reichle A; Rothe G; Krause S; Zaiss M; Ullrich H; Schmitz G; Andreesen R
Leukemia; 1999 Aug; 13(8):1227-34. PubMed ID: 10450751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
